Colorectal cancer: a reality in Luxembourg
Colorectal cancer is one of the most common cancers in both men and women in Luxembourg. Every year, 300 to 400 new cases are recorded according to the National Cancer Registry and the Cancer Foundation. The disease is the second leading cause of death from cancer in the country.
Colorectal cancer often develops without symptoms in its early stages, making it difficult to diagnose in the absence of screening. Yet detected at an early stage, it can be cured in 9 out of 10 cases.
Screening: an essential lever for prevention
Dr Paul-Elie Gosset, Medical Biologist at Bionext, explains: “The mortality rate associated with this disease is gradually decreasing, notably thanks to advances in screening and treatment. However, it remains significant. The many new cases diagnosed each year highlight the importance of active prevention, particularly for people aged 45 and over, as the risk increases with age.”
Screening makes it possible to identify precancerous lesions or cancers in their early stages, offering the possibility of simpler interventions and less burdensome treatments.
The key role of Bionext in the organised colorectal cancer screening programme
Since September 2024, Bionext has been the reference laboratory designated by the Directorate of Health to perform colorectal cancer screening analyses. This mandate was awarded following a public procurement procedure.
Within this framework, Bionext teams have developed an easier-to-use and easier-to-return sampling kit to help increase screening participation rates.
Today, the main challenge remains participation in screening: in Luxembourg, the participation rate is around 45%, compared to nearly 75% in some Nordic countries.
How the program works
On the basis of their invitation, eligible people can obtain their screening kit:
• via MyGuichet
• from the call-center Bionext (+352) 27 321 888
• in Bionext laboratories
• in pharmacies in Luxembourg
For anyone who has already taken part in screening, a new kit is automatically sent every two years.
To find out more about the organised colorectal cancer screening programme and how the test works: www.bionext.lu/pdoccr.
A full version of this article is also available in French.
